1.Misuse of testosterone replacement therapy in men in infertile couples and its influence on infertility treatment
Seung Hun SONG ; Suye SUNG ; Young Sun HER ; Mihee OH ; Dong Hyuk SHIN ; Jinil LEE ; Jeongwon BAEK ; Woo Sik LEE ; Dong Suk KIM
Clinical and Experimental Reproductive Medicine 2019;46(4):173-177
OBJECTIVE: We investigated the clinical characteristics of men with testosterone replacement therapy (TRT)-induced hypogonadism and its effect on assisted reproductive technology (ART) in infertile couples.METHODS: This study examined the records of 20 consecutive male patients diagnosed with azoospermia or severe oligozoospermia (<5×10⁶/mL) who visited a single infertility center from January 2008 to July 2018. All patients were treated at a primary clinic for erectile dysfunction or androgen deficiency symptoms combined with low serum testosterone. All men received a phosphodiesterase 5 inhibitor and TRT with testosterone undecanoate (Nebido®) or testosterone enanthate (Jenasteron®). Patients older than 50 years or with a chronic medical disease such as diabetes were excluded.RESULTS: The mean age of patients was 37 years and the mean duration of infertility was 16.3±11.6 months. At the initial presentation, eight patients had azoospermia, nine had cryptozoospermia, and three had severe oligozoospermia. Serum follicle-stimulating hormone levels were below 1.0 mIU/mL in most patients. Three ongoing ART programs with female factor infertility were cancelled due to male spermatogenic dysfunction; two of these men had normal semen parameters in the previous cycle. After withholding TRT, serum hormone levels and sperm concentrations returned to normal range after a median duration of 8 months.CONCLUSION: TRT with high-dose testosterone can cause spermatogenic dysfunction due to suppression of the hypothalamic-pituitary-testicular axis, with adverse effects on infertility treatment programs. TRT is therefore contraindicated for infertile couples attempting to conceive, and the patient's desire for fertility must be considered before initiation of TRT in a hypogonadal man.
Azoospermia
;
Cyclic Nucleotide Phosphodiesterases, Type 5
;
Erectile Dysfunction
;
Family Characteristics
;
Female
;
Fertility
;
Follicle Stimulating Hormone
;
Humans
;
Hypogonadism
;
Infertility
;
Infertility, Male
;
Male
;
Oligospermia
;
Reference Values
;
Reproductive Techniques, Assisted
;
Semen
;
Spermatozoa
;
Testosterone
2.Delayed recovery of a patient with obstructive azoospermia and a history of acute epididymitis
Seung Hun SONG ; Jeong Yun SHIM ; Suye SUNG ; Young Sun HER ; Mihee OH ; Dong Hyuk SHIN ; Jinil LEE ; Jeoungwon BAEK ; Woo Sik LEE ; Dong Suk KIM
Clinical and Experimental Reproductive Medicine 2019;46(2):95-98
Obstructive azoospermia caused by acute epididymitis is usually permanent, and microsurgical vasoepididymostomy is the only reconstructive treatment option. There have been no reports of delayed recovery of sperm count after over 1 year in a patient with obstructive azoospermia related to history of acute epididymitis. We present a young male patient who had azoospermia and a history of acute epididymitis who experienced delayed recovery, with complete restoration of sperm production and the ability to conceive naturally.
Azoospermia
;
Epididymitis
;
Humans
;
Infertility
;
Male
;
Sperm Count
;
Spermatozoa
3.Impact of the coronavirus disease 2019 pandemic on the incidence of other infectious diseases in the hematology hospital in Korea
Seohee OH ; Yu-Sun SUNG ; Mihee JANG ; Yong-Jin KIM ; Hyun-Wook PARK ; Dukhee NHO ; Dong-Gun LEE ; Hyeon Woo YIM ; Sung-Yeon CHO
The Korean Journal of Internal Medicine 2024;39(3):513-523
Background/Aims:
Since the coronavirus disease 2019 (COVID-19) outbreak, hospitals have implemented infection control measures to minimize the spread of the virus within facilities. This study aimed to investigate the impact of COVID-19 on the incidence of healthcare-associated infections (HCAIs) and common respiratory virus (cRV) infections in hematology units.
Methods:
This retrospective study included all patients hospitalized in Catholic Hematology Hospital between 2019 and 2020. Patients infected with vancomycin-resistant Enterococci (VRE), carbapenemase-producing Enterobacterales (CPE), Clostridium difficile infection (CDI), and cRV were analyzed. The incidence rate ratio (IRR) methods and interrupted time series analyses were performed to compare the incidence rates before and after the pandemic.
Results:
The incidence rates of CPE and VRE did not differ between the two periods. However, the incidence of CDI increased significantly (IRR: 1.41 [p = 0.002]) after the COVID-19 pandemic. The incidence of cRV infection decreased by 76% after the COVID-19 outbreak (IRR: 0.240 [p < 0.001]). The incidence of adenovirus, parainfluenza virus, and rhinovirus infection significantly decreased in the COVID-19 period (IRRs: 0.087 [p = 0.003], 0.031 [p < 0.001], and 0.149 [p < 0.001], respectively).
Conclusions
The implementation of COVID-19 infection control measures reduced the incidence of cRV infection. However, CDI increased significantly and incidence rates of CPE and VRE remained unchanged in hematological patients after the pandemic. Infection control measures suitable for each type of HCAI, such as stringent hand washing for CDI and enough isolation capacities, should be implemented and maintained in future pandemics, especially in immunocompromised patients.